Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Lee

Showing results (311-320 of 343) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
The New England Journal of Medicine|April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2021
Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency StudyJune Corry, Wai Tong Ng, Alisha Moore, et al.
International Journal of Cancer|October 15, 2019
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancerThomas H Beckham, Christian Barney, Erin Healy, et al.
Blood|June 19, 2002
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in miceScott C Kogan, Jerrold M Ward, Miriam R Anver, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 25, 2008
Non-Hodgkin's lymphomasAndrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Pageof 35

Showing results (311-320 of 343) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu-Pei Chen, Nofisat Ismaila, Melvin L K Chua, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
The New England Journal of Medicine|April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2021
Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency StudyJune Corry, Wai Tong Ng, Alisha Moore, et al.
International Journal of Cancer|October 15, 2019
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancerThomas H Beckham, Christian Barney, Erin Healy, et al.
Blood|June 19, 2002
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in miceScott C Kogan, Jerrold M Ward, Miriam R Anver, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 25, 2008
Non-Hodgkin's lymphomasAndrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck CancerMitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Pageof 35